how do you stop taking semaglutide to Rebound Weight Gain After Can I Stop and Restart

Limited research on human subjects: While Dihexa has shown promise in preclinical studies and animal models, there is a scarcity of clinical research evaluating its safety and potential side effect in humans

Certain compounded products may have significant risks, such as dosing errors and contamination

A 2024 randomised trial in adults with elevated fracture risk found that semaglutide reduced hip bone mineral density by 2.6% and lumbar spine density by 2.1% at 52 weeks compared with placebo

At 24 weeks (the last point before people taking a placebo were eligible to switch to orforglipron), people taking a placebo had roughly gained 20 pounds back on average, no matter which drug they were taking originally